| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 13 | / | 2019 | ||||||||
| Date of issue: | 2019-05-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Consolidated Financial report of Sopharma AD for the first quarter of 2019. | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Financial report according to IFRS as at 31 March 2019 consolidated Notes to the financial report as at 31 March 2019 consolidated Management report as at 31 March 2019 consolidated Insider information as at 31 March 2019 consolidated Additional information as at 31 March 2019 consolidated Financial report according to BFCS standards as at 31 March 2019 consolidated Annex 9 as at 31 March 2019 consolidated Declaration of the responsible directors | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Q1_2019_cons_Financial_report.zip | Consolidated Financial report of Sopharma AD for the first quarter of 2019. | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2019-05-30 | Ognian Donev | Executive director | |||
3JR_Q1_2019_cons_Financial_report.zip
